AstraZeneca Outsources Early-Stage COVID-19 Vaccine Manufacturing to Oxford Biomedica
...Oxford University announced an agreement to enable global development, manufacturing and distribution o…
Showing results for 'oxford'
University of Oxford Commences Clinical Trial for Vaccine Candidate (ChAdOx1 nCoV-19) Targeting COVID-19
...Hospital in Oxford. Oxford’s Jenner Institute The University of Oxford
Solving Rising Behavioral Health Challenges with Virtual Reality? Oxford University Spinoff Raises $12.5m
A spinout from Oxford University’s Department of Psychiatry as raised $12.5 million Series A funding…
Oxford’s PRINCIPLE Trial: Bringing Ivermectin Directly into the Developed World in the Battle Against COVID-19
...wrote an urgent email communication to NIH Director Francis Collins. Enter Oxford’s PRINCIPLE Tri…
AstraZeneca Full-Throttle with the Oxford Vaccine Including $1B from BARDA Despite Some Concerning Chatter
...support the ability to deliver worldwide. AZ/Oxford Deal for ChAdOx1 AstreaZeneca has teamed with
Oxford’s PRINCIPLE Trial: Ivermectin Being Considered as Part of the Study
The University of Oxford soon kicks “the PRINCIPLE Trial” into a higher gear now, in what they…
University of Oxford Does it Again! Now Showing that AstraZeneca’s Pulmicort Reduces COVID-19 Hospitalization Rate by 90%
University of Oxford emerges during this pandemic has perhaps the most influential investigational unit wo…
University of Oxford Selects AstraZeneca as its Commercial Partner for its SARS-CoV-2 Vaccine ChAdOx1 nCoV-19
...prominent academic institution’s top SARS-CoV-2 vaccine candidate known as ChAdOx1 nCoV-19. This vaccine has been …
University of Southampton Recruiting Patients for Promising Oxford Vaccine for COVID-19
The University of Southampton is actively recruiting healthy volunteers for a promising early-stage vaccine called ChA…
South African Gov. Halts Temporarily Oxford Vaccine Trial In South Africa Due to Low Efficacy Against the South African Variant
...ease the toll on health care systems by preventing severe disease.” Oxford at Work As a result of…